\-\ Texto\\:\\ \ \(0\)\
\-\ resp\\:\\ r\\ side\\ cta\\,\\ l\\ side\\ with\\ decreased\\ bs\\ and\\ egophany\\ over\\ lower\\ \\?\\ of\\ lung\\.\ \(0\)\
\-\ cvs\\:\\ rrr\\ without\\ r\\/g\\/m\\ \\ \\ \\ \\ extr\\:\\ no\\ c\\/c\\/e\\ \\ \ \(0\)\
\-\ wbc\\ 11\\.4\\,\\ h\\/h\\ 11\\.1\\/34\\,\\ plt\\ 548\ \(0\)\
\-\ 136\\/4\\.8\\/98\\/27\\/12\\/0\\.6\\/106\\ \\ ca\\ 8\\.4\\ \\ alb\\ 2\\.7\\ \\ \\ mg\\ 2\\.2\ \(0\)\
\-\ likely\\ treatment\\ will\\ consist\\ of\\ chemotherapy\\ and\\ radiation\\.\\ there\\ was\\ and\\ currently\\ is\\ discussion\\ of\\ performing\\ vats\\ in\\ this\\ case\\ for\\ further\\ staging\\ and\\ potential\\ treatment\\.\ \(0\)\
\-\ lul\\ mass\\,\\ tracheal\\ deviation\ \(0\)\
\-\ l\\ sided\\ pleural\\ effusion\ \(0\)\
\-\ fissure\\ present\\ as\\ an\\ edge\\ on\\ lateral\\ cxr\ \(0\)\
\-\ spine\\ sign\\ on\\ lateral\\ cxr\ \(0\)\
\-\ indistinct\\ lv\\ heart\\ border\\ on\\ lateral\\ cxr\ \(0\)\
\-\ mass\\ on\\ ct\\ abutting\\ mediastinum\ \(0\)\
\-\ stage\\ iiib\\ adenocarcinoma\ \(0\)\
\-\ lung\\ cancer\ \(74\)\
\-\ granulomatous\\ disease\ \(29\)\
\-\ benign\\ mass\ \(2\)\
\-\ other\\ inflammation\\ \\(pneumonia\\)\ \(0\)\
\-\ congenital\\ abnormality\ \(6\)\
\-\ 56\\ yo\\ female\\ presents\\ for\\ screening\\ x\\-ray\\.\\ she\\ is\\ aymptomatic\\ except\\ for\\ a\\ mild\\ cough\\ and\\ slight\\ \\ fatigue\\ for\\ about\\ one\\ month\\.\ \(0\)\
\-\ adenocarcinoma\\ is\\ the\\ most\\ common\\ form\\ of\\ lung\\ cancer\\ in\\ the\\ us\\.\\ it\\ is\\ associated\\ with\\ smoking\\ although\\ this\\ less\\ strongly\\ than\\ other\\ types\\ of\\ lung\\ cancer\\.\\ adenocarcinomas\\ typically\\ are\\ well\\-defined\\ masses\\ that\\ occur\\ in\\ a\\ peripheral\\ location\\.\\ this\\ type\\ of\\ lung\\ cancer\\ \\ is\\ more\\ common\\ in\\ women\\,\\ usually\\ occurring\\ in\\ current\\ or\\ former\\ smokers\\ although\\ occasionally\\ occurring\\ in\\ non\\-smokers\\.\\ \\ staging\\ involves\\ the\\ tmn\\ system\\ with\\ this\\ patient\\ at\\ stage\\ iiib\\ based\\ on\\ a\\ t4nomo\\ lesion\\ \\(5\\ cm\\ in\\ size\\ with\\ mediastinal\\ invasion\\)\\.\\ \\ \\ surgery\\ is\\ the\\ treatment\\ of\\ choice\\ for\\ stage\\ i\\ and\\ ii\\ lung\\ adenocarcinoma\\.\\ stage\\ iii\\ and\\ iv\\ adenocarcinoma\\ is\\ usually\\ treated\\ with\\ chemotherapy\\ and\\ radiation\\ although\\ there\\ select\\ stage\\ iii\\ and\\ iv\\ cancers\\ may\\ be\\ amenable\\ to\\ surgical\\ treatment\\.\\ \\ median\\ survival\\ for\\ stage\\ iiib\\ lung\\ cancer\\ is\\ 12\\ months\\ and\\ 5\\-year\\ surival\\ is\\ less\\ than\\ 5\\%\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ stage\\:\\ 0\\.29770607434901175\ \(0\)\
\-\ lung\\:\\ 0\\.26531197082245617\ \(0\)\
\-\ iiib\\:\\ 0\\.24963929792691922\ \(0\)\
\-\ cancer\\:\\ 0\\.20750237701077262\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.20370079890739526\ \(0\)\
\-\ smokers\\:\\ 0\\.162042512303298\ \(0\)\
\-\ is\\:\\ 0\\.15356730628572932\ \(0\)\
\-\ cxr\\:\\ 0\\.14953218607435584\ \(0\)\
\-\ and\\:\\ 0\\.12874857070772228\ \(0\)\
\-\ staging\\:\\ 0\\.12728490075027749\ \(0\)\
\-\ although\\:\\ 0\\.127251033693061\ \(0\)\
\-\ occurring\\:\\ 0\\.12572386722843698\ \(0\)\
\-\ treatment\\:\\ 0\\.1187193990543285\ \(0\)\
\-\ for\\:\\ 0\\.11330757041357775\ \(0\)\
\-\ in\\:\\ 0\\.10849869114181072\ \(0\)\
\-\ iii\\:\\ 0\\.10759442345430936\ \(0\)\
\-\ egophany\\:\\ 0\\.09964151573827523\ \(0\)\
\-\ 548\\:\\ 0\\.09964151573827523\ \(0\)\
\-\ aymptomatic\\:\\ 0\\.09964151573827523\ \(0\)\
\-\ t4nomo\\:\\ 0\\.09964151573827523\ \(0\)\
\-\ surival\\:\\ 0\\.09964151573827523\ \(0\)\
\-\ tmn\\:\\ 0\\.0952127877633519\ \(0\)\
\-\ on\\:\\ 0\\.09408802835365707\ \(0\)\
\-\ lateral\\:\\ 0\\.09276391072109437\ \(0\)\
\-\ iv\\:\\ 0\\.08903817595528335\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.0884833480551845\ \(0\)\
\-\ cvs\\:\\ 0\\.08764182728389641\ \(0\)\
\-\ adenocarcinomas\\:\\ 0\\.08764182728389641\ \(0\)\
\-\ side\\:\\ 0\\.08608606675496874\ \(0\)\
\-\ extr\\:\\ 0\\.08595810305102775\ \(0\)\
\-\ this\\:\\ 0\\.08563841981199766\ \(0\)\
\-\ of\\:\\ 0\\.08535162230595178\ \(0\)\
\-\ 12\\:\\ 0\\.08518448732012997\ \(0\)\
\-\ less\\:\\ 0\\.0847761544168715\ \(0\)\
\-\ select\\:\\ 0\\.08449959477936424\ \(0\)\
\-\ amenable\\:\\ 0\\.08321309930897307\ \(0\)\
\-\ radiation\\:\\ 0\\.08257880869664087\ \(0\)\
\-\ vats\\:\\ 0\\.081021256151649\ \(0\)\
\-\ alb\\:\\ 0\\.07919659335507709\ \(0\)\
\-\ usually\\:\\ 0\\.07844838875086096\ \(0\)\
\-\ lul\\:\\ 0\\.07838714257157224\ \(0\)\
\-\ lv\\:\\ 0\\.07626645658538153\ \(0\)\
\-\ former\\:\\ 0\\.07626645658538153\ \(0\)\
\-\ abutting\\:\\ 0\\.07296476742205468\ \(0\)\
\-\ resp\\:\\ 0\\.07162563287562158\ \(0\)\
\-\ indistinct\\:\\ 0\\.07162563287562158\ \(0\)\
\-\ mass\\:\\ 0\\.07139815744411299\ \(0\)\
\-\ consist\\:\\ 0\\.07081618209211675\ \(0\)\
\-\ common\\:\\ 0\\.07066974362773047\ \(0\)\
\-\ than\\:\\ 0\\.07063946618105826\ \(0\)\
\-\ performing\\:\\ 0\\.07006260144136679\ \(0\)\
\-\ tracheal\\:\\ 0\\.06748062441440218\ \(0\)\
\-\ plt\\:\\ 0\\.06692036893683462\ \(0\)\
\-\ cancers\\:\\ 0\\.06692036893683462\ \(0\)\
\-\ other\\:\\ 0\\.06471343937272385\ \(0\)\
\-\ bs\\:\\ 0\\.06448306405321601\ \(0\)\
\-\ median\\:\\ 0\\.06448306405321601\ \(0\)\
\-\ edge\\:\\ 0\\.06286193361421849\ \(0\)\
\-\ deviation\\:\\ 0\\.06267521817626866\ \(0\)\
\-\ strongly\\:\\ 0\\.06267521817626866\ \(0\)\
\-\ with\\:\\ 0\\.0610018713428153\ \(0\)\
\-\ fissure\\:\\ 0\\.06080791672904263\ \(0\)\
\-\ survival\\:\\ 0\\.06080791672904263\ \(0\)\
\-\ fatigue\\:\\ 0\\.06034955910768706\ \(0\)\
\-\ occasionally\\:\\ 0\\.059766882984946\ \(0\)\
\-\ choice\\:\\ 0\\.05907970124468414\ \(0\)\
\-\ cta\\:\\ 0\\.05868723074285191\ \(0\)\
\-\ 56\\:\\ 0\\.058184954336395374\ \(0\)\
\-\ rrr\\:\\ 0\\.058062912986987965\ \(0\)\
\-\ except\\:\\ 0\\.058062912986987965\ \(0\)\
\-\ types\\:\\ 0\\.05794222018837408\ \(0\)\
\-\ smoking\\:\\ 0\\.05770476328994863\ \(0\)\
\-\ women\\:\\ 0\\.056071489895683245\ \(0\)\
\-\ mediastinum\\:\\ 0\\.055772222212608684\ \(0\)\
\-\ potential\\:\\ 0\\.05567426113320575\ \(0\)\
\-\ invasion\\:\\ 0\\.05557717083047154\ \(0\)\
\-\ granulomatous\\:\\ 0\\.05538554157952506\ \(0\)\
\-\ border\\:\\ 0\\.05510425769681315\ \(0\)\
\-\ discussion\\:\\ 0\\.05456253078541646\ \(0\)\
\-\ slight\\:\\ 0\\.05456253078541646\ \(0\)\
\-\ current\\:\\ 0\\.05456253078541646\ \(0\)\
\-\ form\\:\\ 0\\.05447479869014188\ \(0\)\
\-\ mg\\:\\ 0\\.054387765662814586\ \(0\)\
\-\ involves\\:\\ 0\\.05421575286154225\ \(0\)\
\-\ ca\\:\\ 0\\.05315921508767641\ \(0\)\
\-\ screening\\:\\ 0\\.05061399385693987\ \(0\)\
\-\ mediastinal\\:\\ 0\\.05031140976663216\ \(0\)\
\-\ inflammation\\:\\ 0\\.050075236519299786\ \(0\)\
\-\ the\\:\\ 0\\.04972954678847375\ \(0\)\
\-\ there\\:\\ 0\\.049583055342666646\ \(0\)\
\-\ us\\:\\ 0\\.04956180892541375\ \(0\)\
\-\ pneumonia\\:\\ 0\\.049178520926971\ \(0\)\
\-\ ii\\:\\ 0\\.0491248471720917\ \(0\)\
\-\ currently\\:\\ 0\\.047862174147650934\ \(0\)\
\-\ system\\:\\ 0\\.047533297217357655\ \(0\)\
\-\ pleural\\:\\ 0\\.04690383821068638\ \(0\)\
\-\ about\\:\\ 0\\.04664479238208675\ \(0\)\
\-\ cough\\:\\ 0\\.04651753750028453\ \(0\)\
\-\ effusion\\:\\ 0\\.046267390984238356\ \(0\)\
\-\ occur\\:\\ 0\\.045823158008764846\ \(0\)\
\-\ abnormality\\:\\ 0\\.04532043695303232\ \(0\)\
\-\ based\\:\\ 0\\.045133080950490415\ \(0\)\
\-\ congenital\\:\\ 0\\.04476774297603569\ \(0\)\
\-\ peripheral\\:\\ 0\\.04455426542234234\ \(0\)\
\-\ wbc\\:\\ 0\\.04403814167001784\ \(0\)\
\-\ typically\\:\\ 0\\.043739782347968256\ \(0\)\
\-\ location\\:\\ 0\\.04338585312514623\ \(0\)\
\-\ heart\\:\\ 0\\.04332271660750967\ \(0\)\
\-\ sign\\:\\ 0\\.043135467670786264\ \(0\)\
\-\ benign\\:\\ 0\\.04280029922946309\ \(0\)\
\-\ masses\\:\\ 0\\.04241701123102034\ \(0\)\
\-\ size\\:\\ 0\\.04218765714241638\ \(0\)\
\-\ type\\:\\ 0\\.04179752327277586\ \(0\)\
\-\ spine\\:\\ 0\\.041159526633297576\ \(0\)\
\-\ further\\:\\ 0\\.04058121089179025\ \(0\)\
\-\ will\\:\\ 0\\.04010207323401617\ \(0\)\
\-\ sided\\:\\ 0\\.04007865931907292\ \(0\)\
\-\ yo\\:\\ 0\\.03892551127246998\ \(0\)\
\-\ treated\\:\\ 0\\.03879996291158967\ \(0\)\
\-\ decreased\\:\\ 0\\.03859387024760407\ \(0\)\
\-\ month\\:\\ 0\\.037901710117493735\ \(0\)\
\-\ likely\\:\\ 0\\.03723277128412577\ \(0\)\
\-\ she\\:\\ 0\\.037089522186464614\ \(0\)\
\-\ months\\:\\ 0\\.03626737219546195\ \(0\)\
\-\ cm\\:\\ 0\\.03578327876793781\ \(0\)\
\-\ one\\:\\ 0\\.03567334525909284\ \(0\)\
\-\ mild\\:\\ 0\\.03531973309052913\ \(0\)\
\-\ over\\:\\ 0\\.034645103927707914\ \(0\)\
\-\ more\\:\\ 0\\.03421288390970603\ \(0\)\
\-\ surgery\\:\\ 0\\.03349856198362577\ \(0\)\
\-\ without\\:\\ 0\\.03286428939210504\ \(0\)\
\-\ associated\\:\\ 0\\.03284015106816285\ \(0\)\
\-\ most\\:\\ 0\\.03242614314341366\ \(0\)\
\-\ present\\:\\ 0\\.03197144326841676\ \(0\)\
\-\ it\\:\\ 0\\.03189378107229303\ \(0\)\
\-\ lower\\:\\ 0\\.03183864422053862\ \(0\)\
\-\ may\\:\\ 0\\.03135455079301448\ \(0\)\
\-\ case\\:\\ 0\\.03130206348807949\ \(0\)\
\-\ surgical\\:\\ 0\\.030282948305121314\ \(0\)\
\-\ female\\:\\ 0\\.030065717189865063\ \(0\)\
\-\ presents\\:\\ 0\\.029972599940998903\ \(0\)\
\-\ lesion\\:\\ 0\\.029871079600082895\ \(0\)\
\-\ that\\:\\ 0\\.027038645896246678\ \(0\)\
\-\ disease\\:\\ 0\\.02615401799154181\ \(0\)\
\-\ be\\:\\ 0\\.02527522017049915\ \(0\)\
\-\ as\\:\\ 0\\.025030696678376478\ \(0\)\
\-\ an\\:\\ 0\\.023825762517062497\ \(0\)\
\-\ ct\\:\\ 0\\.023720635746549826\ \(0\)\
\-\ are\\:\\ 0\\.023642449391660245\ \(0\)\
\-\ at\\:\\ 0\\.023533920308599993\ \(0\)\
\-\ was\\:\\ 0\\.021714401183956653\ \(0\)\
\-\ or\\:\\ 0\\.02167529102311454\ \(0\)\
\-\ patient\\:\\ 0\\.020265147727876832\ \(0\)\
\-\ no\\:\\ 0\\.02026133597172631\ \(0\)\
\-\ to\\:\\ 0\\.015576480424648797\ \(0\)\
